A sensitive assay for the measurement of serum chondroitin sulfate 3B3(-) epitope levels in human rheumatic diseases

Clinical and Experimental Rheumatology

Volumn 19, Issue 5, 2001, Pages 533-540

  Chan, S S L ^a   Kent, G N ^a   Will, R K ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Arthritis rheumatoid; Chondroitin sulfate; Enzyme linked immunosorbent assay; Keratan sulphate; Osteoarthritis

Indexed keywords

C REACTIVE PROTEIN; CHONDROITIN SULFATE; EPITOPE; KERATAN SULFATE; MONOCLONAL ANTIBODY;

ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; BODY FLUID; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOASSAY; JOINT MOBILITY; MALE; MEASUREMENT; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SAMPLE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SERUM; SYNOVIAL FLUID; VALIDATION PROCESS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ARTHRITIS, RHEUMATOID; CHONDROITIN SULFATES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; JOINTS; MALE; MIDDLE AGED; OSTEOARTHRITIS; RANGE OF MOTION, ARTICULAR; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

EID: 0034820293     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Matrix proteins: Potentials as body fluid markers of changes in the metabolism of cartilage and bone in arthritis
2. Significance of the levels of carboxy terminal Type II procollagen peptide, chondroitin sulfate isomers, tissue inhibitor of metalloproteinases, and metalloproteinases in osteoarthritis joint fluid
3. Urinary collagen cross-links reflect the radiographic severity of knee osteoarthritis
4. Immunological determinants of proteoglycans: Antibodies against the unsaturated oligosaccharide products of chondroitinase ABC-digested cartilage proteoglycans
5. Monoclonal antibodies against chondroitin sulphate isomers: Their use as probes for investigating proteoglycan metabolism
6. Monoclonal antibodies that detect biochemical markers of arthritis in humans
7. Anabolic and catabolic markers of proteoglycan metabolism in osteoarthritis
8. Epitope-specific changes in chondroitin sulfate/dermatan sulfate proteoglycans as markers in the lymphopoietic and granulopoietic compartments of developing bursae of Fabricus
9. Modulation of native chondroitin sulphate structure in tissue development and in disease
10. Development of criteria for the classification and reporting of osteoarthritis
11. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
12. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis
13. Identification of a monoclonal antibody that specifically recognizes corneal and skeletal keratan sulfate: Monoclonal antibodies to cartilage proteoglycan
14. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures
15. Quantification of keratan sulfate in blood as a marker of cartilage catabolism
16. Immunoassay design and optimisation
17. Correlation between synovial fluid markers of cartilage and bone turnover and scintigraphic scan abnormalities in osteoarthritis of the knee
18. Proteoglycans in the synovial fluid of the temporomandibular joint as an indicator of changes in cartilage metabolism during primary and secondary osteoarthritis
19. Biochemical markers in synovial fluid identify early osteoarthritis of the glenohumeral joint
20. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees
21. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury
22. Chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis
23. High levels of aggrecan aggregate components are present in synovial fluids from human knee joints with chronic injury or osteoarthritis
24. Comparison of synovial fluid cartilage marker concentrations and chondral damage assessed arthroscopically in acute knee injury
25. ELISA detection of glycosaminoglycan (GAG)-linked proteoglycans in gingival crevicular fluid
26. The quantitation of a native chondroitin sulfate epitope in synovial fluid lavages and articular cartilage from canine experimental osteoarthritis and disuse atrophy
27. Changes in serum chondroitin sulphate epitopes 3-B-3 and 7-D-4 in early rheumatoid arthritis
28. Glycosoaminoglycan sulfation in human osteoarthritis. Disease-related alterations in the non-reducing termini of chondroitin and dermatan sulfate
29. Changes in sulfation patterns of chondroitin sulfate in equine articular cartilage and synovial fluid in response to aging and osteoarthritis
30. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between different forms of pyridinoline cross-links
31. Keratan sulphate in rheumatoid arthritis, osteoarthritis, and inflammatory diseases
32. Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis
33. Relations between synovial fluid and serum concentrations of osteocalcin and other markers of joint tissue turnover in the knee joint compared with peripheral blood
34. Serum keratan sulfate levels in osteoarthritis patients
35. Serum keratan sulfate: Quantitative and qualitative comparisons in inflammatory versus noninflammatory arthritides
36. Changes in chondroitin sulphate structure induced by joint disease
37. Antigenic properties of keratan sulfate: Influence of antigen structure, monoclonal antibodies, and antibody valency
38. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee